Lymphatic Imaging, Genomic, and pHenotyping Technologies (LIGHT) Program

The Lymphatic Imaging, Genomic, and pHenotyping Technologies (LIGHT) Program, funded by the Advanced Research Projects Agency for Health (ARPA-H) at the Department of Health and Human Services National Institutes of Health, aims to develop a comprehensive diagnostic toolkit to assess lymphatic structure and function. The solicitation is structured into three technical areas: TA1 - Diagnostics and Monitoring, TA2 - Imaging Technologies, and TA3 - Prevention, Prediction & Diagnostic Confirmation. Performers may apply to an integrated track addressing multiple TAs or an individual track focused on a single TA. Key requirements include leveraging computational intelligence, developing commercialization plans, and adhering to equity targets. The solicitation closes on June 27, 2024, and ARPA-H intends to award multiple Other Transaction agreements and/or Cooperative Agreements.

This opportunity is funded through the ARPA-H program at the Department of Health and Human Services, which provides multi-million dollar, multi-year Cooperative Agreements to drive transformative health breakthroughs. The performance will likely take place nationwide through collaborative research networks.